All lobbying filings

LIBERTY PARTNERS GROUP, LLC

Lobbying for ANGIOSAFE (CARDIOVASCULAR COALITION) · Manufacturer of products to treat peripheral artery disease.

Filing 2nd Quarter - Amendment

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Government bodies contacted 4

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 307
ARC Act of 2025
HR 7863
Promoting Fairness for Medicare Providers Act of 2026

Lobbying activity 2

Medicare/Medicaid

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026

Health Issues

Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.